From the Stanford Medicine: Systems Neuroscience and Pain Lab:
"Low-Dose Naltrexone (LDN) for the Treatment of Complex Regional Pain Syndrome (CRPS) is currently enrolling participants."
Here's the link:
CRPS Treatment Study | Systems Neuroscience and Pain Lab | Stanford Medicine